Laskawi R ⚠ 동명이인 가능성

제1저자 또는 공저자로 매칭된 논문 · word-boundary on `authors` column

이름 + 이니셜 1자만으로는 동명이인 구분이 어렵습니다. 상세 비교는 Laskawi R 비교 뷰 →

15 논문
5 최근 5년
1 최근 1년
2016–2026 활동기

주요 저널

  • Fortschritte der Neurologie-Psychiatrie 5
  • Laryngo- rhino- otologie 3
  • Journal of neural transmission (Vienna, Austria : 1996) 3
  • Neurology and therapy 1
  • Medicina oral, patologia oral y cirugia bucal 1
  • HNO 1

주요 공저자 Top 10

  1. Jost WH 7편
  2. Bäumer T 6편
  3. Steffen A 6편
  4. Spittau B 5편
  5. Grosheva M 4편
  6. Winterholler M 4편
  7. Beutner D 3편
  8. Guntinas-Lichius O 3편
  9. Palmowski-Wolfe A 3편
  10. Urban PP 3편

연도별 분포

  • 2026 1
  • 2023 1
  • 2022 2
  • 2021 1
  • 2019 5
  • 2017 4
  • 2016 1

최근 발표

공저자 네트워크

중심 = Laskawi R · 공저 횟수 상위 30
공저자 엣지
본인 공저자 본인-공저자 공저자 사이
⏳ 그래프 로딩 중…

노드 더블클릭 = 해당 저자 페이지로 이동 · 호버 = 공저 횟수 툴팁

논문 목록

15건 · 최신순
  • [Botulinum toxin reduces sweat-related problems for hearing aid users - a clinical study].
    Laryngo- rhino- otologie 2026 Shahpasand S 외 PMID: 42025195

    [OBJECTIVE] Excessive sweating in the head area may cause skin irritation, increased energy consumption, and functional impairment of hearing aids and semi-implantable hearing systems. This study investigated the frequency of sweat-related …

  • Botulinum neurotoxin type A in the interdisciplinary treatment of sialorrhea in adults and children-update and practice recommendations.
    Frontiers in neurology 2023 Jost WH 외 PMID: 38162447

    Sialorrhea is defined as a chronic excessive flow of saliva from the mouth, often with adverse consequences for health and quality of life of patients. In addition to currently used non-drug treatment and systemic drugs, intraglandular Botu…

  • [Therapy of Hemifacial Spasm with Botulinum Toxin: an Update].
    Fortschritte der Neurologie-Psychiatrie 2022 Jost WH 외 PMID: 35021244

    Injections of botulinum toxin can be viewed by now as the therapy of choice in treating hemifacial spasm (HFS). Each of the three botulinum toxin-A preparations have been approved for this indication in Germany. HFS is a frequent disease ch…

  • [Therapy of Sialorrhea with Botulinum Toxin - An Update].
    Fortschritte der Neurologie-Psychiatrie 2022 Jost WH 외 PMID: 35453157

    The most important salivary glands are the paired parotid and submandibular glands. Adults produce 1 to 1.5 liters of saliva which are then regularly swallowed. When the act of swallowing is disturbed, salivation occurs. More rarely, the ca…

  • Oral health and oral health-related quality of life in patients with oral dystonia indicates their need for dental special care.
    Medicina oral, patologia oral y cirugia bucal 2021 Schmalz G 외 PMID: 34023846

    [BACKGROUND] This retrospective study aimed in the evaluation of oral health and oral health-related quality of life (OHRQoL) of patients with oral dystonia (OD). [MATERIAL AND METHODS] Seventeen patients with OD (Meige Syndrome: n=11, Oro…

  • [Therapy of Hemifacial Spasm with Botulinum Toxin].
    Laryngo- rhino- otologie 2019 Jost WH 외 PMID: 30968378

    Hemifacial spasm (HFS) is a frequent disorder characterized by involuntary contractions of those muscles innervated by the facialis nerve on one side of the face. The symptoms can appear as tonic or clonic, intermittent or permanent. Diagno…

  • [Hypersalivation - Update of the S2k guideline (AWMF) in short form].
    Laryngo- rhino- otologie 2019 Steffen A 외 PMID: 31167292

    Hypersalivation describes a relatively excessive salivary flow, which wets the patient himself and his surroundings. It may result because of insufficient oro-motor function, dysphagia, decreased central control and coordination. This updat…

  • Hypersalivation: update of the German S2k guideline (AWMF) in short form.
    Journal of neural transmission (Vienna, Austria : 1996) 2019 Steffen A 외 PMID: 30972507

    Hypersalivation describes a relatively excessive salivary flow, which wets the patient himself and his surroundings. It may result because of insufficient oro-motor function, dysphagia, decreased central control and coordination. This updat…

  • [Therapy of sialorrhea with botulinum toxin].
    Fortschritte der Neurologie-Psychiatrie 2019 Jost WH 외 PMID: 31344747

    The most important salivary glands are the paired parotid and submandibular glands. Adults produce 1 to 1.5 liters of saliva which are then regularly swallowed. When the act of swallowing is disturbed, salivation occurs. More rarely, the ca…

  • Therapy of Sialorrhea with Botulinum Neurotoxin.
    Neurology and therapy 2019 Jost WH 외 PMID: 31542879

    Botulinum neurotoxin (BoNT) is considered the treatment of choice for various symptoms and diseases such as focal dystonia and focal spasticity. The effects of BoNT on the salivary glands have also been known for years, but their use was li…

  • Frontalis suspension surgery to treat patients with blepharospasm and eyelid opening apraxia: long-term results.
    Journal of neural transmission (Vienna, Austria : 1996) 2017 Dressler D 외 PMID: 27816991

    Blepharospasm may be accompanied by eyelid opening apraxia (EOA) reducing the efficacy of botulinum toxin (BT) therapy. The frontalis suspension operation (FSO) is then the only effective treatment option available. We want to report the fi…

  • [Therapy of Hemifacial Spasm with Botulinum Toxin].
    Fortschritte der Neurologie-Psychiatrie 2017 Jost WH 외 PMID: 28437820

    Hemifacial spasm (HFS) is a frequent disorder characterized by involuntary contractions of those muscles innervated by the facialis nerve on one side of the face. The symptoms can appear as tonic or clonic, intermittent or permanent. Diagno…

  • [Treatment of laryngeal dystonia with botulinum toxin].
    Fortschritte der Neurologie-Psychiatrie 2017 Olthoff A 외 PMID: 28841743

    The treatment of laryngeal dystonias with botulinum toxin is successful. Every patient suffering from a laryngeal dystonia should be assured of high quality therapeutic intervention. Therefore it is important to establish general standards …

  • [Botulinum toxin in otorhinolaryngology - an update].
    HNO 2017 Laskawi R (제1저자) PMID: 28861590

    During recent decades, the clinical use of botulinum toxin has become increasingly well established. In the field of otorhinolaryngology there are many indications for which botulinum toxin can improve patients' quality of life. These inclu…

  • Strategies for treatment of dystonia.
    Journal of neural transmission (Vienna, Austria : 1996) 2016 Dressler D 외 PMID: 26370676

    Treatment of dystonias is generally symptomatic. To produce sufficient therapy effects, therefore, frequently a multimodal and interdisciplinary therapeutic approach becomes necessary, combining botulinum toxin therapy, deep brain stimulati…